Tower Bridge Advisors’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-24,315
Closed -$1.62M 216
2016
Q4
$1.62M Sell
24,315
-14,665
-38% -$954K 0.2% 97
2016
Q3
$2.58M Buy
38,980
+355
+0.9% +$24.3K 0.31% 86
2016
Q2
$2.8M Sell
38,625
-700
-2% -$48.1K 0.35% 79
2016
Q1
$2.54M Buy
39,325
+100
+0.3% +$6.63K 0.32% 82
2015
Q4
$2.81M Buy
39,225
+12,995
+50% +$961K 0.37% 78
2015
Q3
$2.01M Buy
26,230
+1,455
+6% +$117K 0.28% 86
2015
Q2
$1.84M Buy
24,775
+6,605
+36% +$475K 0.23% 97
2015
Q1
$1.32M Buy
18,170
+10,145
+126% +$705K 0.17% 101
2014
Q4
$531K Buy
+8,025
New +$490K 0.07% 142

Other funds holding MD

Tower Bridge Advisors's MD Position: Q1 2017 in Review

Tower Bridge Advisors sold out of Pediatrix Medical (MD) in Q1 2017, closing a stake of 24,315 shares — an estimated $1.62M sold.

Tower Bridge Advisors first reported a position in MD in Q4 2014 and held it in 9 quarters. The position peaked at $2.81M in Q4 2015. 359 funds tracked by Wall St. Rank hold MD as of Q1 2017.

  • Tower Bridge Advisors reported no remaining Pediatrix Medical position as of Q1 2017 after selling out during the quarter.
  • Tower Bridge Advisors sold 24,315 Pediatrix Medical shares in Q1 2017, an estimated $1.62M.
  • Tower Bridge Advisors first reported a position in Pediatrix Medical in Q4 2014 and held it in 9 quarters.
  • Tower Bridge Advisors's Pediatrix Medical position peaked at $2.81M in Q4 2015.
  • 359 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2017.

Based on Tower Bridge Advisors's 13F filing for Q1 2017, filed 2 May 2017.